{"id":32980,"date":"2021-06-04T17:00:00","date_gmt":"2021-06-04T10:00:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2021060417000032980"},"modified":"2021-06-05T21:36:53","modified_gmt":"2021-06-05T13:36:53","slug":"%e6%b3%9b%e7%94%9f%e5%ad%9016%e9%a1%b9%e7%99%8c%e7%97%87%e9%a2%86%e5%9f%9f%e7%a0%94%e7%a9%b6%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82021%e7%be%8e%e5%9b%bd%e4%b8%b4%e5%ba%8a%e8%82%bf%e7%98%a4%e5%ad%a6","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2021060417000032980","title":{"rendered":"\u6cdb\u751f\u5b5016\u9879\u764c\u75c7\u9886\u57df\u7814\u7a76\u6210\u679c\u4eae\u76f82021\u7f8e\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\u5e74\u4f1a(ASCO)"},"content":{"rendered":"<p><p>\u5317\u4eac2021\u5e746\u67084\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; <b>\u57282021\u5e74\u7f8e\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\u5e74\u4f1a\uff08ASCO2021\uff09\u4e2d\uff0c\u6cdb\u751f\u5b50\uff08\u7eb3\u65af\u8fbe\u514b\u4ee3\u7801\uff1aGTH\uff09\u53d1\u5e0316\u9879\u7814\u7a76\u6210\u679c\uff0c\u8986\u76d6\u80ba\u764c\u3001\u8180\u80f1\u764c\u3001\u7532\u72b6\u817a\u764c\u7b49\u8fd1\u5341\u79cd\u9ad8\u53d1\u764c\u79cd(\u9644\u7814\u7a76\u5217\u8868)\uff0c\u4e3a\u9884\u9632\u3001\u9274\u522b\u8bca\u65ad\u53ca\u7528\u836f\u6307\u5bfc\u7b49\u764c\u75c7\u5168\u5468\u671f\u7684\u79d1\u5b66\u7814\u7a76\u4e0e\u4e34\u5e8a\u7ba1\u7406\u63d0\u4f9b\u91cd\u8981\u542f\u793a\u3002\u8fd9\u4e9b\u7814\u7a76\u6210\u679c\u7531\u6cdb\u751f\u5b50\u643a\u624b16\u5bb6\u56fd\u5185\u9876\u7ea7\u533b\u9662\u5b8c\u6210\uff0c\u4f9d\u6258\u516c\u53f8\u4e13\u5229\u6280\u672f\u201c\u4e00\u6b65\u6cd5\u201d\uff08\u4e2d\u56fd\u53d1\u660e\u4e13\u5229ZL201710218529.4\uff09\uff0c\u53caOnco Panscan<sup>TM<\/sup>\u3001\u5168\u5916\u663e\u5b50\u68c0\u6d4b\u3001\u5c3f\u8def\u4e0a\u76ae\u80bf\u7624\u98ce\u9669\u57fa\u56e0\u68c0\u6d4b\u3001\u7532\u72b6\u817a\u764c\u5168\u5468\u671f\u57fa\u56e0\u68c0\u6d4b\u7b49\u6838\u5fc3\u4ea7\u54c1\uff0c\u5bf9\u4e34\u5e8a\u5e38\u89c4\u8bca\u65ad\u65b9\u6cd5\u8fdb\u884c\u4f18\u5316\uff0c\u5e76\u5bf9\u5927\u961f\u5217\u4eba\u7fa4\u57fa\u56e0\u7a81\u53d8\u53ca\u878d\u5408\u3001\u514d\u75ab\u6cbb\u7597\u6807\u5fd7\u7269\u3001\u9057\u4f20\u6027\u80bf\u7624\u6807\u5fd7\u7269\u7684\u7279\u5f81\u56fe\u8c31\u8fdb\u884c\u7ed8\u5236\u3002<\/b><\/p>\n<p><b>\u6cdb\u751f\u5b50\u9996\u5e2d\u533b\u7597\u5b98\u80e1\u4e91\u5bcc\u535a\u58eb\u8868\u793a\uff1a<\/b>\u201c\u6cdb\u751f\u5b50\u672c\u6b21\u7814\u7a76\u6210\u679c\uff0c\u4e3a\u591a\u764c\u79cd\u5728\u4e0d\u540c\u53d1\u5c55\u9636\u6bb5\u7684\u7cbe\u51c6\u8bca\u7597\u63d0\u4f9b\u4e86\u65b0\u7b56\u7565\uff0c\u8d4b\u80fd\u764c\u75c7\u5168\u5468\u671f\u7ba1\u7406\uff1a\u5982\u5bf9\u80ba\u764c\u9057\u4f20\u56e0\u7d20\u7684\u7814\u7a76\u7ed3\u679c\uff0c\u6216\u53ef\u52a9\u529b\u80ba\u764c\u60a3\u8005\u66f4\u65e9\u9884\u9632\u3001\u786e\u8bca\uff1b\u5bf9\u80be\u76c2\u764c\u3001\u8180\u80f1\u764c\u3001\u7532\u72b6\u817a\u764c\u5e38\u89c4\u8bca\u65ad\u65b9\u6cd5\u7684\u8865\u5145\uff0c\u5c06\u63d0\u5347\u60a3\u8005\u68c0\u51fa\u7387\uff1b\u5bf9\u591a\u764c\u79cd\u4eba\u7fa4\u4e2d\u7a81\u53d8\u3001\u878d\u5408\u3001MSI\u7b49\u6807\u5fd7\u7269\u7279\u5f81\u56fe\u8c31\u7684\u63a2\u7d22\uff0c\u5c06\u4e3a\u65b0\u4ea7\u54c1\u8bbe\u8ba1\u63d0\u4f9b\u601d\u8def\uff0c\u4e3a\u60a3\u8005\u63d0\u4f9b\u66f4\u591a\u9776\u5411\u53ca\u514d\u75ab\u6cbb\u7597\u83b7\u76ca\u53ef\u80fd\u3002\u201d<\/p>\n<p><b>\u4f18\u5316\u4e34\u5e8a\u5e38\u89c4\u8bca\u65ad\u65b9\u6cd5<\/b><\/p>\n<p>\u4e3a\u964d\u4f4e\u7531\u8f93\u5c3f\u7ba1\u955c\u3001\u8180\u80f1\u955c\u7684\u5f3a\u4fb5\u5165\u6027\u800c\u5e26\u7ed9\u60a3\u8005\u7684\u75db\u82e6\u53ca\u98ce\u9669\uff0c\u6cdb\u751f\u5b50\u4f9d\u6258\u201c\u4e00\u6b65\u6cd5\u201d\u5f00\u53d1\u4e86\u5c3f\u8def\u4e0a\u76ae\u80bf\u7624\u98ce\u9669\u57fa\u56e0\u68c0\u6d4b\uff0c\u53ef\u65e0\u521b\u3001\u7cbe\u51c6\u7684\u8f85\u52a9\u8bca\u65ad\u3002\u7814\u7a76#e16500\u53ca#e16509\u8868\u660e\u8be5\u4ea7\u54c1\u5728\u80be\u76c2\u764c\u961f\u5217\u548c\u8180\u80f1\u764c\u961f\u5217\u4e2d\uff0c\u5206\u522b\u5b9e\u73b0\u4e8693%\u548c86%\u7684\u7075\u654f\u5ea6\uff0c\u663e\u8457\u4f18\u4e8e\u540c\u4e3a\u65e0\u521b\u624b\u6bb5\u7684\u5c3f\u8131\u843d\u7ec6\u80deFISH<span id=\"spanHghlt6707\">\u68c0\u6d4b\u3002<\/span><\/p>\n<p>\u901a\u8fc7\u8d85\u58f0\u548c\u8d85\u58f0\u5f15\u5bfc\u4e0b\u7684\u7ec6\u9488\u7a7f\u523a\u6d3b\u68c0\uff08FNA\uff09\u662f\u5224\u65ad\u7532\u72b6\u817a\u826f\u6076\u6027\u7ed3\u8282\u7684\u4e3b\u8981\u65b9\u6cd5\u3002\u5bf9\u4e8eFNA\u65e0\u6cd5\u660e\u786e\u8bca\u65ad\u7684\u60a3\u8005\uff0c\u6cdb\u751f\u5b50\u4f9d\u6258\u201c\u4e00\u6b65\u6cd5\u201d\u5f00\u53d1\u4e86\u7532\u72b6\u817a\u764c\u5168\u5468\u671f\u57fa\u56e0\u68c0\u6d4b\u3002\u7814\u7a76#e15028\u521d\u6b65\u6570\u636e\u8868\u660e\u8be5\u4ea7\u54c1\u53ef\u8f85\u52a9\u533a\u5206\u7532\u72b6\u817a\u7ed3\u8282\u826f\u6076\u6027\uff0c\u4e3a\u6cbb\u7597\u51b3\u7b56\u63d0\u4f9b\u53c2\u8003\u4f9d\u636e\u3002<\/p>\n<p><b>\u63a2\u7d22\u57fa\u56e0\u7a81\u53d8\u53ca\u878d\u5408\u5206\u5e03\u7279\u5f81<\/b><\/p>\n<p>\u4e03\u9879\u7814\u7a76\uff08#e21577\u3001#e16143\u3001#e16042\u3001#8573\u3001#e21074\u3001#3055\u3001#4121\uff09\u5206\u522b\u5bf9\u9ed1\u8272\u7d20\u7624\u3001\u80c6\u56ca\u764c\u3001\u98df\u7ba1\u764c\u3001\u80f8\u817a\u7624\u3001\u80ba\u764c\u3001\u7532\u72b6\u817a\u764c\u3001\u80f0\u817a\u764c\u8fdb\u884c\u7a81\u53d8\u3001\u878d\u5408\u7279\u5f81\u591a\u7ef4\u5ea6\u63a2\u7d22\uff0c\u5bfb\u627e\u6f5c\u5728\u7cbe\u51c6\u6cbb\u7597\u9776\u70b9\u3001\u8010\u836f\u9776\u70b9\u53ca\u6709\u6548\u5e94\u5bf9\u63aa\u65bd\u3002<\/p>\n<p><b>\u63a2\u7d22\u514d\u75ab\u6cbb\u7597\u6807\u5fd7\u7269\u5206\u5e03\u7279\u5f81<\/b><\/p>\n<p>\u4e94\u9879\u7814\u7a76\uff08#2606\u3001#2586\u3001#e14575\u3001#e14576\u3001#2587\uff09\u5206\u522b\u63a2\u8ba8\u4e86POLE\/POLD1\u7a81\u53d8\u3001HMTs\u529f\u80fd\u7f3a\u5931\u7a81\u53d8\u3001TMB\u53ca\u8d85\u7a81\u53d8\u3001MSI\u3001KMT2C\/D\u529f\u80fd\u7f3a\u5931\u7a81\u53d8\u5728\u591a\u764c\u79cd\u4eba\u7fa4\u4e2d\u7684\u5206\u5e03\u7279\u5f81\u53ca\u5176\u5bf9\u514d\u75ab\u6cbb\u7597\u7597\u6548\u7684\u9884\u6d4b\u4f5c\u7528\uff0c\u4e3a\u514d\u75ab\u6cbb\u7597\u63d0\u4f9b\u542f\u793a\u3002<\/p>\n<p><b>\u63a2\u7d22\u9057\u4f20\u6027\u80bf\u7624\u6807\u5fd7\u7269\u5206\u5e03\u7279\u5f81<\/b><\/p>\n<p>\u7814\u7a76#e20511\u901a\u8fc7\u5bf9\u80ba\u764c\u60a3\u8005\u80da\u7cfb\u7a81\u53d8\u7684\u6df1\u5165\u5206\u6790\uff0c\u63a2\u8ba8\u4e86\u9057\u4f20\u56e0\u7d20\u4e0e\u80ba\u764c\u53d1\u5c55\u7684\u76f8\u5173\u6027\uff0c\u6709\u52a9\u4e8e\u9610\u660e\u80ba\u764c\u7684\u53d1\u75c5\u673a\u5236\uff0c\u52a9\u529b\u80ba\u764c\u7684\u53ca\u65e9\u53d1\u73b0\u53ca\u8bca\u65ad\uff0c\u5e76\u4e3a\u5176\u9884\u9632\u53ca\u9776\u5411\u6cbb\u7597\u63d0\u4f9b\u7b56\u7565\u3002<\/p>\n<div>\n<table cellspacing=\"0\" cellpadding=\"0\" border=\"0\" class=\"prntblns\">\n<tbody>\n<tr>\n<td class=\"prnsbts prnrbrs prnvab prnsbbs prnpl6 prnsbls prnpr6\">\n<p class=\"prnews_p\"><span class=\"prnews_span\"><b>\u7f16\u53f7<\/b><\/span><\/p>\n<\/td>\n<td class=\"prnsbts prnrbrs prnvab prnsbbs prntac prnpl6 prnsbl1 prnpr6\">\n<p class=\"prnews_p\"><span class=\"prnews_span\"><b>\u9898\u76ee<\/b><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2586<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">The predictive values of loss-of-function variants in histone methyltransferases for response to immune checkpoint inhibitors in solid tumors<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2587<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Association of KMT2C\/D loss-of-function mutations with tumor&nbsp;infiltrating&nbsp;lymphocytes and response to immune checkpoint inhibitors in solid&nbsp;tumors<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2606<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Investigating the various predictive values of POLE\/POLD1 mutations for response to immune checkpoint inhibitors (ICIs) in different solid tumors<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">3055<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Differences of US-FNA BSRTC class, postoperative pathology and mutation landscape of thyroid nodules between China and other countries<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">4121<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Genomic profiling of KRAS wide-type pancreatic ductal adenocarcinomas identifies targetable genetic alterations<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">8573<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Myasthenia gravis-associated thymoma and myasthenia gravis-free thymoma have distinct somatic mutation and gene expression profiles<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">e14575<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Exploration of the TMB and hypermutation&nbsp;Landscape in Chinese pan-Cancer patient by NEXT-GENERATION SEQUENCING<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">e14576<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Exploration of the&nbsp;MSI landscape&nbsp;in Chinese pan-cancer patient by NEXT-GENERATION SEQUENCING<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">e15028<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Significance of molecular detection in diagnosis of benign and malignant thyroid nodules in China<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">e16143<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Evaluation of somatic and germline mutations in Chinese patients with gallbladder carcinoma reveals clinically actionable targets<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">e16042<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Genomic profiling of esophageal squamous cell carcinoma reveals actionable genetic alterations<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">e16500<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Accuracy of an urine-based liquid biopsy genetic test in detecting renal pelvic cancer<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">e16509<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">A multicenter, prospective evaluation of a urine-based assay for bladder cancer diagnosis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">e20511<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Genomic features of lung cancer patients harboring germlinemutations associated with hereditary cancer syndromes<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">e21074<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Identification of RET fusion as mechanisms of resistance toEGFR tyrosine-kinase inhibitors<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">e21577<\/span><\/p>\n<\/td>\n<td class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Genetic landscape of melanoma in China reveals enrichment of fusions in driver-negative melanoma<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<p>&nbsp;<\/p>\n<p><b>\u5173\u4e8e\u6cdb\u751f\u5b50<\/b><\/p>\n<p>\u6cdb\u751f\u5b50\uff08\u7eb3\u65af\u8fbe\u514b\u4ee3\u7801\uff1aGTH\uff09\u662f\u5168\u7403\u524d\u6cbf\u7684\u764c\u75c7\u7cbe\u51c6\u533b\u7597\u516c\u53f8\uff0c\u4e13\u6ce8\u4e8e\u764c\u75c7\u57fa\u56e0\u7ec4\u5b66\u7814\u7a76\u548c\u5e94\u7528\uff0c\u5e76\u81f4\u529b\u4f9d\u6258\u5148\u8fdb\u7684\u5206\u5b50\u751f\u7269\u5b66\u53ca\u5927\u6570\u636e\u5206\u6790\u80fd\u529b\u6539\u53d8\u764c\u75c7\u8bca\u7597\u65b9\u5f0f\u3002\u6cdb\u751f\u5b50\u5df2\u6253\u9020\u4e86\u5168\u9762\u7684\u4ea7\u54c1\u53ca\u670d\u52a1\u7ba1\u7ebf\uff0c\u8986\u76d6\u4ece\u764c\u75c7\u65e9\u7b5b\u5230\u8bca\u65ad\u53ca\u6cbb\u7597\u5efa\u8bae\uff0c\u518d\u5230\u76d1\u6d4b\u53ca\u9884\u540e\u7ba1\u7406\u7684\u764c\u75c7\u5168\u5468\u671f\uff0c\u5e76\u4e0e\u4ea7\u4e1a\u94fe\u4e0a\u4e0b\u6e38\u5408\u4f5c\u4f19\u4f34\u79ef\u6781\u62d3\u5c55\u5206\u5b50\u68c0\u6d4b\u6280\u672f\u7684\u66f4\u591a\u521b\u65b0\u5e94\u7528\u65b9\u5411\u548c\u573a\u666f\u3002\u66f4\u591a\u516c\u53f8\u4fe1\u606f\u8bf7\u8bbf\u95ee\uff1a<a target=\"_blank\" href=\"https:\/\/www.genetronhealth.com\/\" rel=\"nofollow noopener\">https:\/\/www.genetronhealth.com\/<\/a>\u3002<\/p>\n<p><b>\u5b89\u5168\u6e2f\u58f0\u660e<\/b><\/p>\n<p>\u672c\u65b0\u95fb\u7a3f\u5305\u542b\u6cdb\u751f\u5b50\u5bf9\u672a\u6765\u7684\u9884\u671f\u3001\u8ba1\u5212\u548c\u524d\u77bb\u6027\u9648\u8ff0\uff0c\u5305\u62ec\u9488\u5bf9\u7814\u7a76\u6210\u679c\u53ca\u57fa\u56e0\u7ec4\u5b66\u63a2\u7d22\u3001\u201c\u4e00\u6b65\u6cd5\u201d\u4ee5\u53ca\u5e38\u89c4\u4e34\u5e8a\u8bca\u65ad\u65b9\u6cd5\u4f18\u5316\u7814\u7a76\u7684\u9648\u8ff0\uff0c\u5177\u6709\u76f8\u5e94\u98ce\u9669\u53ca\u4e0d\u786e\u5b9a\u6027\uff0c\u53ef\u80fd\u5bfc\u81f4\u5b9e\u9645\u7ed3\u679c\u4e0e\u524d\u77bb\u6027\u9648\u8ff0\u4e2d\u63cf\u8ff0\u7684\u9884\u671f\u4e0d\u7b26\u3002\u6b64\u7c7b\u9648\u8ff0\u662f\u6839\u636e1995\u5e74\u7f8e\u56fd\u79c1\u6709\u8bc1\u5238\u8bc9\u8bbc\u6539\u9769\u6cd5\u6848\u7684\u201c\u5b89\u5168\u6e2f\u201d\u6761\u6b3e\u4f5c\u51fa\u7684\u3002\u524d\u77bb\u6027\u9648\u8ff0\u6d89\u53ca\u56fa\u6709\u98ce\u9669\u3001\u4e0d\u786e\u5b9a\u6027\uff0c\u4ee5\u53ca\u8bb8\u591a\u53ef\u80fd\u5bfc\u81f4\u5b9e\u9645\u7ed3\u679c\u4e0e\u4efb\u4f55\u524d\u77bb\u6027\u9648\u8ff0\u4e2d\u6240\u63cf\u8ff0\u7684\u5185\u5bb9\u4ea7\u751f\u91cd\u5927\u5dee\u5f02\u7684\u56e0\u7d20\u3002\u5176\u5b83\u5305\u542b\u6709\u201c\u9884\u671f\u201d\u3001\u201c\u76f8\u4fe1\u201d\u3001\u201c\u671f\u5f85\u201d\u3001\u201c\u8ba1\u5212\u201d\u7b49\u63aa\u8f9e\u548c\u7c7b\u4f3c\u8868\u8fbe\u4e5f\u5c5e\u4e8e\u524d\u77bb\u6027\u63cf\u8ff0\u3002\u66f4\u591a\u6709\u5173\u8fd9\u4e9b\u5185\u5bb9\u53ca\u5176\u4ed6\u98ce\u9669\u3001\u4e0d\u786e\u5b9a\u6027\u56e0\u7d20\u7684\u4fe1\u606f\uff0c\u5df2\u5305\u542b\u5728\u516c\u53f8\u5411\u7f8e\u56fd\u8bc1\u5238\u4ea4\u6613\u59d4\u5458\u4f1a\u63d0\u4ea4\u7684\u5907\u6848\u6587\u4ef6\u4e2d\u3002\u672c\u65b0\u95fb\u7a3f\u4e2d\u63d0\u4f9b\u7684\u6240\u6709\u4fe1\u606f\u4e0d\u5e94\u88ab\u89c6\u4e3a\u672c\u516c\u544a\u53d1\u5e03\u4e4b\u65e5\u540e\u4efb\u4f55\u65f6\u70b9\u7684\u89c2\u70b9\u3002\u6cdb\u751f\u5b50\u9884\u8ba1\u672a\u6765\u7684\u4e8b\u4ef6\u548c\u8fdb\u5c55\u4f1a\u5bfc\u81f4\u516c\u53f8\u7684\u8bbe\u60f3\u548c\u5047\u8bbe\u53d1\u751f\u53d8\u5316\uff0c\u4f46\u65e0\u8bba\u662f\u5426\u51fa\u73b0\u4e86\u65b0\u7684\u4fe1\u606f\u3001\u672a\u6765\u4e8b\u4ef6\u6216\u5176\u5b83\u60c5\u51b5\uff0c\u9664\u9002\u7528\u6cd5\u5f8b\u8981\u6c42\u5916\uff0c\u516c\u53f8\u4e0d\u627f\u62c5\u66f4\u65b0\u4efb\u4f55\u524d\u77bb\u6027\u63cf\u8ff0\u7684\u4e49\u52a1\u3002<\/p>\n<p>\u76f8\u5173\u94fe\u63a5 :<\/p>\n<p>https:\/\/www.genetronhealth.com\/<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5317\u4eac2021\u5e746\u67084\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u57282021\u5e74\u7f8e\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\u5e74\u4f1a\uff08ASCO2021\uff09\u4e2d\uff0c\u6cdb\u751f\u5b50\uff08\u7eb3\u65af\u8fbe\u514b\u4ee3\u7801\uff1aGTH\uff09\u53d1\u5e0316\u9879\u7814\u7a76\u6210\u679c\uff0c\u8986\u76d6\u80ba\u764c\u3001\u8180\u80f1\u764c\u3001\u7532\u72b6\u817a\u764c\u7b49\u8fd1\u5341\u79cd\u9ad8\u53d1\u764c\u79cd(\u9644\u7814\u7a76\u5217\u8868)\uff0c\u4e3a\u9884\u9632\u3001\u9274\u522b\u8bca\u65ad\u53ca\u7528\u836f\u6307\u5bfc\u7b49\u764c\u75c7\u5168\u5468\u671f\u7684\u79d1\u5b66\u7814\u7a76\u4e0e\u4e34\u5e8a\u7ba1\u7406\u63d0\u4f9b\u91cd\u8981\u542f\u793a\u3002\u8fd9\u4e9b\u7814\u7a76\u6210\u679c\u7531\u6cdb\u751f\u5b50\u643a\u624b16\u5bb6\u56fd\u5185\u9876\u7ea7\u533b\u9662\u5b8c\u6210\uff0c\u4f9d\u6258\u516c\u53f8\u4e13\u5229\u6280\u672f\u201c\u4e00\u6b65\u6cd5\u201d\uff08\u4e2d\u56fd\u53d1\u660e\u4e13\u5229ZL201710218529.4\uff09\uff0c\u53caOnco PanscanTM\u3001\u5168\u5916\u663e\u5b50\u68c0\u6d4b\u3001\u5c3f\u8def\u4e0a\u76ae\u80bf\u7624\u98ce\u9669\u57fa\u56e0\u68c0\u6d4b\u3001\u7532\u72b6\u817a\u764c\u5168\u5468\u671f\u57fa\u56e0\u68c0\u6d4b\u7b49\u6838\u5fc3\u4ea7\u54c1\uff0c\u5bf9\u4e34\u5e8a\u5e38\u89c4\u8bca\u65ad\u65b9\u6cd5\u8fdb\u884c\u4f18\u5316\uff0c\u5e76\u5bf9\u5927\u961f\u5217\u4eba\u7fa4\u57fa\u56e0\u7a81\u53d8\u53ca\u878d\u5408\u3001\u514d\u75ab\u6cbb\u7597\u6807\u5fd7\u7269\u3001\u9057\u4f20\u6027\u80bf\u7624\u6807\u5fd7\u7269\u7684\u7279\u5f81\u56fe\u8c31\u8fdb\u884c\u7ed8\u5236\u3002 \u6cdb\u751f\u5b50\u9996\u5e2d\u533b\u7597\u5b98\u80e1\u4e91\u5bcc\u535a\u58eb\u8868\u793a\uff1a\u201c\u6cdb\u751f\u5b50\u672c\u6b21\u7814\u7a76\u6210\u679c\uff0c\u4e3a\u591a\u764c\u79cd\u5728\u4e0d\u540c\u53d1\u5c55\u9636\u6bb5\u7684\u7cbe\u51c6\u8bca\u7597\u63d0\u4f9b\u4e86\u65b0\u7b56\u7565\uff0c\u8d4b\u80fd\u764c\u75c7\u5168\u5468\u671f\u7ba1\u7406\uff1a\u5982\u5bf9\u80ba\u764c\u9057\u4f20\u56e0\u7d20\u7684\u7814\u7a76\u7ed3\u679c\uff0c\u6216\u53ef\u52a9\u529b\u80ba\u764c\u60a3\u8005\u66f4\u65e9\u9884\u9632\u3001\u786e\u8bca\uff1b\u5bf9\u80be\u76c2\u764c\u3001\u8180\u80f1\u764c\u3001\u7532\u72b6\u817a\u764c\u5e38\u89c4\u8bca\u65ad\u65b9\u6cd5\u7684\u8865\u5145\uff0c\u5c06\u63d0\u5347\u60a3\u8005\u68c0\u51fa\u7387\uff1b\u5bf9\u591a\u764c\u79cd\u4eba\u7fa4\u4e2d\u7a81\u53d8\u3001\u878d\u5408\u3001MSI\u7b49\u6807\u5fd7\u7269\u7279\u5f81\u56fe\u8c31\u7684\u63a2\u7d22\uff0c\u5c06\u4e3a\u65b0\u4ea7\u54c1\u8bbe\u8ba1\u63d0\u4f9b\u601d\u8def\uff0c\u4e3a\u60a3\u8005\u63d0\u4f9b\u66f4\u591a\u9776\u5411\u53ca\u514d\u75ab\u6cbb\u7597\u83b7\u76ca\u53ef\u80fd\u3002\u201d \u4f18\u5316\u4e34\u5e8a\u5e38\u89c4\u8bca\u65ad\u65b9\u6cd5 \u4e3a\u964d\u4f4e\u7531\u8f93\u5c3f\u7ba1\u955c\u3001\u8180\u80f1\u955c\u7684\u5f3a\u4fb5\u5165\u6027\u800c\u5e26\u7ed9\u60a3\u8005\u7684\u75db\u82e6\u53ca\u98ce\u9669\uff0c\u6cdb\u751f\u5b50\u4f9d\u6258\u201c\u4e00\u6b65\u6cd5\u201d\u5f00\u53d1\u4e86\u5c3f\u8def\u4e0a\u76ae\u80bf\u7624\u98ce\u9669\u57fa\u56e0\u68c0\u6d4b\uff0c\u53ef\u65e0\u521b\u3001\u7cbe\u51c6\u7684\u8f85\u52a9\u8bca\u65ad\u3002\u7814\u7a76#e16500\u53ca#e16509\u8868\u660e\u8be5\u4ea7\u54c1\u5728\u80be\u76c2\u764c\u961f\u5217\u548c\u8180\u80f1\u764c\u961f\u5217\u4e2d\uff0c\u5206\u522b\u5b9e\u73b0\u4e8693%\u548c86%\u7684\u7075\u654f\u5ea6\uff0c\u663e\u8457\u4f18\u4e8e\u540c\u4e3a\u65e0\u521b\u624b\u6bb5\u7684\u5c3f\u8131\u843d\u7ec6\u80deFISH\u68c0\u6d4b\u3002 \u901a\u8fc7\u8d85\u58f0\u548c\u8d85\u58f0\u5f15\u5bfc\u4e0b\u7684\u7ec6\u9488\u7a7f\u523a\u6d3b\u68c0\uff08FNA\uff09\u662f\u5224\u65ad\u7532\u72b6\u817a\u826f\u6076\u6027\u7ed3\u8282\u7684\u4e3b\u8981\u65b9\u6cd5\u3002\u5bf9\u4e8eFNA\u65e0\u6cd5\u660e\u786e\u8bca\u65ad\u7684\u60a3\u8005\uff0c\u6cdb\u751f\u5b50\u4f9d\u6258\u201c\u4e00\u6b65\u6cd5\u201d\u5f00\u53d1\u4e86\u7532\u72b6\u817a\u764c\u5168\u5468\u671f\u57fa\u56e0\u68c0\u6d4b\u3002\u7814\u7a76#e15028\u521d\u6b65\u6570\u636e\u8868\u660e\u8be5\u4ea7\u54c1\u53ef\u8f85\u52a9\u533a\u5206\u7532\u72b6\u817a\u7ed3\u8282\u826f\u6076\u6027\uff0c\u4e3a\u6cbb\u7597\u51b3\u7b56\u63d0\u4f9b\u53c2\u8003\u4f9d\u636e\u3002 \u63a2\u7d22\u57fa\u56e0\u7a81\u53d8\u53ca\u878d\u5408\u5206\u5e03\u7279\u5f81 \u4e03\u9879\u7814\u7a76\uff08#e21577\u3001#e16143\u3001#e16042\u3001#8573\u3001#e21074\u3001#3055\u3001#4121\uff09\u5206\u522b\u5bf9\u9ed1\u8272\u7d20\u7624\u3001\u80c6\u56ca\u764c\u3001\u98df\u7ba1\u764c\u3001\u80f8\u817a\u7624\u3001\u80ba\u764c\u3001\u7532\u72b6\u817a\u764c\u3001\u80f0\u817a\u764c\u8fdb\u884c\u7a81\u53d8\u3001\u878d\u5408\u7279\u5f81\u591a\u7ef4\u5ea6\u63a2\u7d22\uff0c\u5bfb\u627e\u6f5c\u5728\u7cbe\u51c6\u6cbb\u7597\u9776\u70b9\u3001\u8010\u836f\u9776\u70b9\u53ca\u6709\u6548\u5e94\u5bf9\u63aa\u65bd\u3002 \u63a2\u7d22\u514d\u75ab\u6cbb\u7597\u6807\u5fd7\u7269\u5206\u5e03\u7279\u5f81 \u4e94\u9879\u7814\u7a76\uff08#2606\u3001#2586\u3001#e14575\u3001#e14576\u3001#2587\uff09\u5206\u522b\u63a2\u8ba8\u4e86POLE\/POLD1\u7a81\u53d8\u3001HMTs\u529f\u80fd\u7f3a\u5931\u7a81\u53d8\u3001TMB\u53ca\u8d85\u7a81\u53d8\u3001MSI\u3001KMT2C\/D\u529f\u80fd\u7f3a\u5931\u7a81\u53d8\u5728\u591a\u764c\u79cd\u4eba\u7fa4\u4e2d\u7684\u5206\u5e03\u7279\u5f81\u53ca\u5176\u5bf9\u514d\u75ab\u6cbb\u7597\u7597\u6548\u7684\u9884\u6d4b\u4f5c\u7528\uff0c\u4e3a\u514d\u75ab\u6cbb\u7597\u63d0\u4f9b\u542f\u793a\u3002 \u63a2\u7d22\u9057\u4f20\u6027\u80bf\u7624\u6807\u5fd7\u7269\u5206\u5e03\u7279\u5f81 \u7814\u7a76#e20511\u901a\u8fc7\u5bf9\u80ba\u764c\u60a3\u8005\u80da\u7cfb\u7a81\u53d8\u7684\u6df1\u5165\u5206\u6790\uff0c\u63a2\u8ba8\u4e86\u9057\u4f20\u56e0\u7d20\u4e0e\u80ba\u764c\u53d1\u5c55\u7684\u76f8\u5173\u6027\uff0c\u6709\u52a9\u4e8e\u9610\u660e\u80ba\u764c\u7684\u53d1\u75c5\u673a\u5236\uff0c\u52a9\u529b\u80ba\u764c\u7684\u53ca\u65e9\u53d1\u73b0\u53ca\u8bca\u65ad\uff0c\u5e76\u4e3a\u5176\u9884\u9632\u53ca\u9776\u5411\u6cbb\u7597\u63d0\u4f9b\u7b56\u7565\u3002 \u7f16\u53f7 \u9898\u76ee 2586 The predictive values of loss-of-function variants in histone methyltransferases for response to immune checkpoint inhibitors in solid tumors 2587 Association of KMT2C\/D loss-of-function mutations with tumor&nbsp;infiltrating&nbsp;lymphocytes and response to immune checkpoint inhibitors in solid&nbsp;tumors 2606 Investigating the&hellip; <a class=\"read-more\" href=\"https:\/\/www.xinwengao.com\/cn\/pr\/2021060417000032980\">Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":8278,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-32980","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/32980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=32980"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/32980\/revisions"}],"predecessor-version":[{"id":32981,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/32980\/revisions\/32981"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/8278"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=32980"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=32980"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=32980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}